| 0006-0717 | HYZAAR ® 50/12.5 (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLETS) HYZAAR ® 100/12.5 (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLETS) HYZAAR ® 100/25 (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLETS) | Aphena Pharma Solutions - Tennessee, LLC |
| 0006-0747 | HYZAAR ® 50-12.5 (LOSARTAN POTASSIUM-HYDROCHLOROTHIAZIDE TABLETS) HYZAAR ® 100-12.5 (LOSARTAN POTASSIUM-HYDROCHLOROTHIAZIDE TABLETS) HYZAAR ® 100-25 (LOSARTAN POTASSIUM-HYDROCHLOROTHIAZIDE TABLETS) | Rebel Distributors Corp |
| 0024-5855 | These highlights do not include all the information needed to use AVALIDE safely and effectively. See full prescribing information for AVALIDE. AVALIDE ® (irbesartan and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 1997 | Sanofi-Aventis U.S. LLC | Sanofi Winthrop Industrie | EUROAPI Hungary Ltd. | Eurofins Lancaster Laboratories, Inc | CAMBREX PROFARMACO MILANO S.R.L. |
| 0024-5855-30 | These highlights do not include all the information needed to use AVALIDE safely and effectively. See full prescribing information for AVALIDE. AVALIDE ® (irbesartan and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 1997 | Sanofi-Aventis U.S. LLC | Sanofi Winthrop Industrie | EUROAPI Hungary Ltd. | Eurofins Lancaster Laboratories, Inc | CAMBREX PROFARMACO MILANO S.R.L. |
| 0024-5855-90 | These highlights do not include all the information needed to use AVALIDE safely and effectively. See full prescribing information for AVALIDE. AVALIDE ® (irbesartan and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 1997 | Sanofi-Aventis U.S. LLC | Sanofi Winthrop Industrie | EUROAPI Hungary Ltd. | Eurofins Lancaster Laboratories, Inc | CAMBREX PROFARMACO MILANO S.R.L. |
| 0024-5856 | These highlights do not include all the information needed to use AVALIDE safely and effectively. See full prescribing information for AVALIDE. AVALIDE ® (irbesartan and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 1997 | Sanofi-Aventis U.S. LLC | Sanofi Winthrop Industrie | EUROAPI Hungary Ltd. | Eurofins Lancaster Laboratories, Inc | CAMBREX PROFARMACO MILANO S.R.L. |
| 0024-5856-30 | These highlights do not include all the information needed to use AVALIDE safely and effectively. See full prescribing information for AVALIDE. AVALIDE ® (irbesartan and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 1997 | Sanofi-Aventis U.S. LLC | Sanofi Winthrop Industrie | EUROAPI Hungary Ltd. | Eurofins Lancaster Laboratories, Inc | CAMBREX PROFARMACO MILANO S.R.L. |
| 0024-5856-90 | These highlights do not include all the information needed to use AVALIDE safely and effectively. See full prescribing information for AVALIDE. AVALIDE ® (irbesartan and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 1997 | Sanofi-Aventis U.S. LLC | Sanofi Winthrop Industrie | EUROAPI Hungary Ltd. | Eurofins Lancaster Laboratories, Inc | CAMBREX PROFARMACO MILANO S.R.L. |
| 0054-0102 | Amlodipine Besylate Tablets, 2.5 mg, 5 mg, and 10 mg | State of Florida DOH Central Pharmacy |
| 0054-0127 | Losartan Potassium and Hydrochlorothiazide Tablets USP | Aidarex Pharmaceuticals LLC |
| 0054-0254 | These highlights do not include all the information needed to use IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS. IRBESARTAN and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 1997 | Hikma Pharmaceuticals USA Inc. | West-Ward Columbus Inc. |
| 0054-0254-13 | These highlights do not include all the information needed to use IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS. IRBESARTAN and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 1997 | Hikma Pharmaceuticals USA Inc. | West-Ward Columbus Inc. |
| 0054-0254-22 | These highlights do not include all the information needed to use IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS. IRBESARTAN and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 1997 | Hikma Pharmaceuticals USA Inc. | West-Ward Columbus Inc. |
| 0054-0254-29 | These highlights do not include all the information needed to use IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS. IRBESARTAN and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 1997 | Hikma Pharmaceuticals USA Inc. | West-Ward Columbus Inc. |
| 0054-0255 | These highlights do not include all the information needed to use IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS. IRBESARTAN and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 1997 | Hikma Pharmaceuticals USA Inc. | West-Ward Columbus Inc. |
| 0054-0255-13 | These highlights do not include all the information needed to use IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS. IRBESARTAN and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 1997 | Hikma Pharmaceuticals USA Inc. | West-Ward Columbus Inc. |
| 0054-0255-22 | These highlights do not include all the information needed to use IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS. IRBESARTAN and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 1997 | Hikma Pharmaceuticals USA Inc. | West-Ward Columbus Inc. |
| 0054-0255-29 | These highlights do not include all the information needed to use IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS. IRBESARTAN and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 1997 | Hikma Pharmaceuticals USA Inc. | West-Ward Columbus Inc. |
| 0054-0256 | These highlights do not include all the information needed to use IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS. IRBESARTAN and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 1997 | Hikma Pharmaceuticals USA Inc. | West-Ward Columbus Inc. |
| 0054-0256-13 | These highlights do not include all the information needed to use IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS. IRBESARTAN and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 1997 | Hikma Pharmaceuticals USA Inc. | West-Ward Columbus Inc. |
| 0054-0256-22 | These highlights do not include all the information needed to use IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS. IRBESARTAN and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 1997 | Hikma Pharmaceuticals USA Inc. | West-Ward Columbus Inc. |
| 0054-0256-29 | These highlights do not include all the information needed to use IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS. IRBESARTAN and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 1997 | Hikma Pharmaceuticals USA Inc. | West-Ward Columbus Inc. |
| 0069-1520 | These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1992 | PFIZER LABORATORIES DIV PFIZER INC |
| 0069-1520-68 | These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1992 | PFIZER LABORATORIES DIV PFIZER INC |
| 0069-1530 | These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1992 | PFIZER LABORATORIES DIV PFIZER INC |
| 0069-1530 | These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1987 | Rebel Distributors Corp |
| 0069-1530-41 | These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1992 | PFIZER LABORATORIES DIV PFIZER INC |
| 0069-1530-68 | These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1992 | PFIZER LABORATORIES DIV PFIZER INC |
| 0069-1530-72 | These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1992 | PFIZER LABORATORIES DIV PFIZER INC |
| 0069-1540 | These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1992 | PFIZER LABORATORIES DIV PFIZER INC |
| 0069-1540-41 | These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1992 | PFIZER LABORATORIES DIV PFIZER INC |
| 0069-1540-68 | These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1992 | PFIZER LABORATORIES DIV PFIZER INC |
| 0069-2150 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 0069-2150 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-2150-30 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-2160 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-2160 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 0069-2160-30 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-2170 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-2170 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 0069-2170-30 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-2180 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-2180 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 0069-2180-30 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-2190 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-2190 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 0069-2190-30 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-2250 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-2250 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 0069-2250-30 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-2260 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-2260 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 0069-2260-30 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-2270 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-2270 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 0069-2270-30 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-2970 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 0069-2980 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 0069-6180 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-6180-30 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-6323 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-6323-30 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-6565 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-6565-30 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-6747 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-6747-30 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-7232 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-7232-30 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-7476 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-7476-30 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-7654 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-7654-30 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-7810 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0069-7810-30 | These highlights do not include all the information needed to use CADUET safely and effectively. See full prescribing information for CADUET. CADUET ® (amlodipine and atorvastatin) tablets, for oral use Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH |
| 0074-3015 | TEVETEN ® HCT (eprosartan mesylate/hydrochlorothiazide)600/12.5mg 600/25mg | Physicians Total Care, Inc. |
| 0078-0314 | These highlights do not include all the information needed to use Diovan HCT safely and effectively. See full prescribing information for Diovan HCT. Diovan HCT (valsartan and hydrochlorothiazide USP) Tablets Initial U.S. Approval: 1998 | Dispensing Solutions, Inc. | PSS World Medical Inc. |
| 0078-0314 | These highlights do not include all the information needed to use Diovan HCT safely and effectively. See full prescribing information for Diovan HCT. Diovan HCT (valsartan and hydrochlorothiazide USP) Tablets Initial U.S. Approval : 1998 | Physicians Total Care, Inc. |
| 0078-0315 | These highlights do not include all the information needed to use Diovan HCT safely and effectively. See full prescribing information for Diovan HCT. Diovan HCT (valsartan and hydrochlorothiazide USP) Tablets Initial U.S. Approval : 1998 | Physicians Total Care, Inc. |
| 0078-0315 | These highlights do not include all the information needed to use Diovan HCT safely and effectively. See full prescribing information for Diovan HCT. Diovan HCT ® (valsartan and hydrochlorothiazide USP) Tablets Initial U.S. Approval: 1998 | Dispensing Solutions, Inc. | PSS World Medical, Inc. |
| 0078-0364 | These highlights do not include all the information needed to use LOTREL safely and effectively. See full prescribing information for LOTREL. LOTREL (amlodipine and benazepril hydrochloride) capsules, for oral use Initial U.S. Approval: 1995 | Novartis Pharmaceuticals Corporation |
| 0078-0364 | These highlights do not include all the information needed to use Lotrel safely and effectively. See full prescribing information for Lotrel. Lotrel (amlodipine besylate and benazepril hydrochloride) Capsules Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 0078-0364-05 | These highlights do not include all the information needed to use LOTREL safely and effectively. See full prescribing information for LOTREL. LOTREL (amlodipine and benazepril hydrochloride) capsules, for oral use Initial U.S. Approval: 1995 | Novartis Pharmaceuticals Corporation |
| 0078-0379 | These highlights do not include all the information needed to use LOTREL safely and effectively. See full prescribing information for LOTREL. LOTREL (amlodipine and benazepril hydrochloride) capsules, for oral use Initial U.S. Approval: 1995 | Novartis Pharmaceuticals Corporation |
| 0078-0379 | These highlights do not include all the information needed to use Lotrel safely and effectively. See full prescribing information for Lotrel. Lotrel (amlodipine besylate and benazepril hydrochloride) Capsules Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 0078-0379-05 | These highlights do not include all the information needed to use LOTREL safely and effectively. See full prescribing information for LOTREL. LOTREL (amlodipine and benazepril hydrochloride) capsules, for oral use Initial U.S. Approval: 1995 | Novartis Pharmaceuticals Corporation |
| 0078-0383 | These highlights do not include all the information needed to use Diovan HCT safely and effectively. See full prescribing information for Diovan HCT. Diovan HCT (valsartan and hydrochlorothiazide USP) Tablets Initial U.S. Approval: 1998 | Dispensing Solutions, Inc. | PSS World Medical, Inc. |
| 0078-0383 | These highlights do not include all the information needed to use Diovan HCT safely and effectively. See full prescribing information for Diovan HCT. Diovan HCT (valsartan and hydrochlorothiazide USP) Tablets Initial U.S. Approval : 1998 | Physicians Total Care, Inc. |
| 0078-0383 | These highlights do not include all the information needed to use Diovan HCT safely and effectively. See full prescribing information for Diovan HCT. Diovan HCT ® (valsartan and hydrochlorothiazide USP) Tablets Initial U.S. Approval: 1998 | Dispensing Solutions, Inc. | PSS World Medical, Inc. |
| 0078-0384 | These highlights do not include all the information needed to use Lotrel safely and effectively. See full prescribing information for Lotrel. Lotrel (amlodipine besylate and benazepril hydrochloride) Capsules Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 0078-0404 | These highlights do not include all the information needed to use Lotrel safely and effectively. See full prescribing information for Lotrel. Lotrel (amlodipine besylate and benazepril hydrochloride) Capsules Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 0078-0405 | These highlights do not include all the information needed to use Lotrel safely and effectively. See full prescribing information for Lotrel. Lotrel (amlodipine besylate and benazepril hydrochloride) Capsules Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 0078-0405 | These highlights do not include all the information needed to use LOTREL safely and effectively. See full prescribing information for LOTREL. LOTREL (amlodipine and benazepril hydrochloride) capsules, for oral use Initial U.S. Approval: 1995 | Novartis Pharmaceuticals Corporation |
| 0078-0405-05 | These highlights do not include all the information needed to use LOTREL safely and effectively. See full prescribing information for LOTREL. LOTREL (amlodipine and benazepril hydrochloride) capsules, for oral use Initial U.S. Approval: 1995 | Novartis Pharmaceuticals Corporation |
| 0078-0406 | These highlights do not include all the information needed to use LOTREL safely and effectively. See full prescribing information for LOTREL. LOTREL (amlodipine and benazepril hydrochloride) capsules, for oral use Initial U.S. Approval: 1995 | Novartis Pharmaceuticals Corporation |
| 0078-0406 | These highlights do not include all the information needed to use Lotrel safely and effectively. See full prescribing information for Lotrel. Lotrel (amlodipine besylate and benazepril hydrochloride) Capsules Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 0078-0406-05 | These highlights do not include all the information needed to use LOTREL safely and effectively. See full prescribing information for LOTREL. LOTREL (amlodipine and benazepril hydrochloride) capsules, for oral use Initial U.S. Approval: 1995 | Novartis Pharmaceuticals Corporation |
| 0078-0453 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 0078-0454 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 0078-0471 | These highlights do not include all the information needed to use Diovan HCT safely and effectively. See full prescribing information for Diovan HCT. Diovan HCT (valsartan and hydrochlorothiazide USP) Tablets Initial U.S. Approval : 1998 | Physicians Total Care, Inc. |
| 0078-0472 | These highlights do not include all the information needed to use Diovan HCT safely and effectively. See full prescribing information for Diovan HCT. Diovan HCT (valsartan and hydrochlorothiazide USP) Tablets Initial U.S. Approval : 1998 | Physicians Total Care, Inc. |
| 0078-0488 | These highlights do not include all the information needed to use EXFORGE safely and effectively. See full prescribing information for EXFORGE. EXFORGE ® (amlodipine and valsartan) tablets, for oral use Initial U.S. Approval: 2007 | Novartis Pharmaceuticals Corporation |
| 0078-0488 | These highlights do not include all the information needed to use Exforge safely and effectively . See full prescribing information for Exforge . Exforge (amlodipine and valsartan) Tablets Initial U.S. Approval: 2007 | Physicians Total Care, Inc. |
| 0078-0488-15 | These highlights do not include all the information needed to use EXFORGE safely and effectively. See full prescribing information for EXFORGE. EXFORGE ® (amlodipine and valsartan) tablets, for oral use Initial U.S. Approval: 2007 | Novartis Pharmaceuticals Corporation |
| 0078-0489 | These highlights do not include all the information needed to use EXFORGE safely and effectively. See full prescribing information for EXFORGE. EXFORGE ® (amlodipine and valsartan) tablets, for oral use Initial U.S. Approval: 2007 | Novartis Pharmaceuticals Corporation |
| 0078-0489 | These highlights do not include all the information needed to use Exforge safely and effectively . See full prescribing information for Exforge . Exforge (amlodipine and valsartan) Tablets Initial U.S. Approval: 2007 | Physicians Total Care, Inc. |
| 0078-0489-15 | These highlights do not include all the information needed to use EXFORGE safely and effectively. See full prescribing information for EXFORGE. EXFORGE ® (amlodipine and valsartan) tablets, for oral use Initial U.S. Approval: 2007 | Novartis Pharmaceuticals Corporation |
| 0078-0490 | These highlights do not include all the information needed to use EXFORGE safely and effectively. See full prescribing information for EXFORGE. EXFORGE ® (amlodipine and valsartan) tablets, for oral use Initial U.S. Approval: 2007 | Novartis Pharmaceuticals Corporation |
| 0078-0490 | These highlights do not include all the information needed to use Exforge safely and effectively . See full prescribing information for Exforge . Exforge (amlodipine and valsartan) Tablets Initial U.S. Approval: 2007 | Physicians Total Care, Inc. |
| 0078-0490-15 | These highlights do not include all the information needed to use EXFORGE safely and effectively. See full prescribing information for EXFORGE. EXFORGE ® (amlodipine and valsartan) tablets, for oral use Initial U.S. Approval: 2007 | Novartis Pharmaceuticals Corporation |
| 0078-0491 | These highlights do not include all the information needed to use EXFORGE safely and effectively. See full prescribing information for EXFORGE. EXFORGE ® (amlodipine and valsartan) tablets, for oral use Initial U.S. Approval: 2007 | Novartis Pharmaceuticals Corporation |
| 0078-0491 | These highlights do not include all the information needed to use Exforge safely and effectively . See full prescribing information for Exforge . Exforge (amlodipine and valsartan) Tablets Initial U.S. Approval: 2007 | Physicians Total Care, Inc. |
| 0078-0491-15 | These highlights do not include all the information needed to use EXFORGE safely and effectively. See full prescribing information for EXFORGE. EXFORGE ® (amlodipine and valsartan) tablets, for oral use Initial U.S. Approval: 2007 | Novartis Pharmaceuticals Corporation |
| 0078-0521 | These highlights do not include all the information needed to use Tekturna HCT safely and effectively. See full prescribing information for Tekturna HCT . Tekturna HCT (aliskiren and hydrochlorothiazide) T ablets Initial U.S. Approval: 2008 | Physicians Total Care, Inc. |
| 0078-0523 | These highlights do not include all the information needed to use Tekturna HCT safely and effectively. See full prescribing information for Tekturna HCT . Tekturna HCT (aliskiren and hydrochlorothiazide) T ablets Initial U.S. Approval: 2008 | Physicians Total Care, Inc. |
| 0078-0524 | These highlights do not include all the information needed to use Tekturna HCT safely and effectively. See full prescribing information for Tekturna HCT . Tekturna HCT (aliskiren and hydrochlorothiazide) T ablets Initial U.S. Approval: 2008 | Physicians Total Care, Inc. |
| 0078-0559 | These highlights do not include all the information needed to use EXFORGE HCT safely and effectively. See full prescribing information for EXFORGE HCT. EXFORGE HCT ® (amlodipine, valsartan, and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 2009 | Novartis Pharmaceuticals Corporation |
| 0078-0559-15 | These highlights do not include all the information needed to use EXFORGE HCT safely and effectively. See full prescribing information for EXFORGE HCT. EXFORGE HCT ® (amlodipine, valsartan, and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 2009 | Novartis Pharmaceuticals Corporation |
| 0078-0559-30 | These highlights do not include all the information needed to use EXFORGE HCT safely and effectively. See full prescribing information for EXFORGE HCT. EXFORGE HCT ® (amlodipine, valsartan, and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 2009 | Novartis Pharmaceuticals Corporation |
| 0078-0560 | These highlights do not include all the information needed to use EXFORGE HCT safely and effectively. See full prescribing information for EXFORGE HCT. EXFORGE HCT ® (amlodipine, valsartan, and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 2009 | Novartis Pharmaceuticals Corporation |
| 0078-0560-15 | These highlights do not include all the information needed to use EXFORGE HCT safely and effectively. See full prescribing information for EXFORGE HCT. EXFORGE HCT ® (amlodipine, valsartan, and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 2009 | Novartis Pharmaceuticals Corporation |